文献速递癫痫

衰弱与老年癫痫患者抗癫痫药物耐受性的关联

Association Between Frailty and Antiseizure Medication Tolerability in Older Adults With Epilepsy.
PubMed 文献 · Neurology · 2022-12-19

埃德蒙顿衰弱评分在构建效度上表现最佳。

要点

  • 埃德蒙顿衰弱评分每增加1分,利物浦不良事件概况评分增加1.83分(95%CI 0.67-4.30)。
  • 临床衰弱量表评分每增加1分,利物浦不良事件概况评分增加2.49分(95%CI 1.27-2.39)。
  • 衰弱评分及握力与癫痫发作频率均无显著关联。

核心结论

  • 埃德蒙顿衰弱评分与抗癫痫药物耐受性在统计学和临床上均显著相关。
  • 在评估老年癫痫患者衰弱方面,埃德蒙顿衰弱评分较其他两种测量工具表现出多个优势。
  • 未来研究须关注埃德蒙顿衰弱评分在癫痫诊断时可能对老年癫痫患者抗癫痫药物选择发挥的作用。

研究设计与样本

  • 研究招募了来自加拿大4家医院中心的60岁及以上活动性癫痫患者。
  • 共纳入43名女性和43名男性,年龄60-93岁,其中87%为局灶性癫痫。
  • 采用3种衰弱测量:握力(身体衰弱)、埃德蒙顿衰弱评分(EFS,自报)和临床衰弱量表(CFS,医务人员完成)。
  • 抗癫痫药物耐受性采用利物浦不良事件概况(LAEP)量化。
  • 还使用标准化问卷评估焦虑、抑郁、功能残疾和生活质量,并收集临床和人口学数据。

主要发现

  • 患者平均癫痫发作频率为每月3.4次。
  • 埃德蒙顿衰弱评分每增加1分,LAEP评分增加1.83分(95%CI 0.67-4.30)。
  • 临床衰弱量表评分每增加1分,LAEP评分增加2.49分(95%CI 1.27-2.39)。
  • 埃德蒙顿衰弱评分和临床衰弱量表评分及握力均与癫痫发作频率无显著关联。
  • 埃德蒙顿衰弱评分与抑郁、焦虑、生活质量和功能残疾呈中度相关,在3种测试的衰弱测量中表现出最佳的构建效度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Frailty is an important aspect of biological aging, referring to the increased vulnerability of individuals with frailty to physical and psychological stressors. While older adults with epilepsy are an important and distinct clinical group, there are no data on frailty in this population. We hypothesize that frailty will correlate with the seizure frequency and especially the tolerability of antiseizure medications (ASMs) in older adults with epilepsy. METHODS: We recruited individuals aged 60 years or older with active epilepsy from 4 Canadian hospital centers. We reported the seizure frequency in the 3 months preceding the interview, while ASM tolerability was quantified using the Liverpool Adverse Events Profile (LAEP). We applied 3 measures of frailty: grip strength as a measure of physical frailty, 1 self-reported score (Edmonton frail score [EFS]), and 1 scale completed by a healthcare professional (clinical frailty scale [CFS]). We also administered standardized questionnaires measuring levels of anxiety, depression, functional disability, and quality of life and obtained relevant clinical and demographic data. RESULTS: Forty-three women and 43 men aged 60-93 years were recruited, 87% of whom had focal epilepsy, with an average frequency of 3.4 seizures per month. Multiple linear regression and zero-inflated negative binomial regression models showed that EFS and CFS scores were associated with decreased ASM tolerability, each point increase leading to 1.83 (95% CI: 0.67-4.30) and 2.49 (95% CI: 1.27-2.39) point increases on the LAEP scale, respectively. Neither the EFS and CFS scores nor grip strength were significantly associated with seizure frequency. The EFS was moderately correlated with depression, anxiety, quality of life, and functional disability, demonstrating the best construct validity among the 3 tested measures of frailty. DISCUSSION: The EFS was significantly, both statistically and clinically, associated with ASM tolerability. It also showed multiple advantages in performance while assessing for frailty in older adults with epilepsy, when compared with the 2 other measures of frailty that we tested. Future studies must focus on what role the EFS during epilepsy diagnosis may play in ASM selection among older adults with epilepsy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Vary-O'Neal A, Miranzadeh S, Husein N, et al. Association Between Frailty and Antiseizure Medication Tolerability in Older Adults With Epilepsy. Neurology. 2022. PMID: 36535780. doi:10.1212/WNL.0000000000201701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。